SCHEMBL16619064

SCHEMBL16619064

CC(=O)c1c[nH]c2ccc(C(F)(F)F)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
CYP1A2 P05177 1/20 0.54
ALOX12 P18054 1/20 0.54
HSD17B10 Q99714 2/20 0.50
KDM4E B2RXH2 2/20 0.50
KIF11 P52732 2/20 0.46
HASPIN Q8TF76 1/20 0.46
TP53 P04637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
IDO1 P14902 1/20 0.45
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
NR4A2 P43354 1/20 0.43
IGF1R P08069 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465827 0.87 ALDH1A1 (0.68) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL24143313 0.86 MEN1 (0.52) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL1466529 0.84 NR4A2 (0.65) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL28183396 0.84 MEN1 (0.50) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL17026963 0.84 KMT2A (0.50) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL17026903 0.84 SMN1; SMN2 (0.52) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL27532481 0.82 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL2535362 0.82 ALDH1A1 (0.51) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL6030740 0.81 MEN1 (0.48) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL5912516 0.80 KDM4E (0.64) PBRM1KMT2AALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052495-B1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2019-06-26 EP disclosed
EP-3052495-B1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2019-06-26 EP disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER (US) 2016-08-11 US disclosed
EP-3052495-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS Pfizer Inc. (US) 2016-08-10 EP disclosed
WO-2015049616-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2015-04-09 WO disclosed
WO-2015049616-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS PFIZER INC. (US) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229847-A1 NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS BACE1, BACE2, PSEN2 PBRM1 1562/4885MEN1 3008/4885KMT2A 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.